UPEXI, INC. (UPXI) Latest Filing Signal
Cross-checked across multiple AI analysts and grounded in the latest SEC filing.
powered by: earningsVibe.ai
Question:
What is the latest filing signal for UPEXI, INC.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest
10-Q, UPEXI, INC.'s filing signal
turned negative.
earningsVibe SuperAnalyst™ Verdict:
TURNED NEGATIVE
Signal Performance — Stock Price Since Filing
30-Day Change
-4.62%
from filing date
60-Day Change
+12.82%
from filing date
Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT
PERPLEXITY
Turned Positive
GEMINI
Turned Negative
CLAUDE
Turned Negative
CHATGPT
Turned Negative
Unlock the Full Filing Analysis
See full earningsSig™ and risksSig™ analysis across 5,000+ companies
Get Started Free →No credit card required
Question:
What does UPEXI, INC. actually do?
Answer:
Upexi, Inc. is a diversified company with a dual focus on consumer products and a treasury strategy centered on Solana (SOL) digital assets. The company develops, manufactures, and distributes a range of consumer goods, including pet care products under the LuckyTail brand and functional mushroom extracts from Cure Mushrooms, utilizing direct-to-consumer and wholesale channels. Concurrently, Upexi has shifted its treasury strategy to hold and stake Solana tokens, aiming to generate yield and benefit from potential price appreciation, managed by an asset manager. The company operates from Florida, with its executive offices in Tampa and a manufacturing facility in Odessa.
Question:
What are UPEXI, INC.'s revenue drivers?
Answer:
Revenue is generated from the sale of consumer products across various brands and from staking rewards earned on its Solana digital asset treasury.
Cut through noisy SEC filings to find the signal faster
Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.
Get Started Free →No credit card required